|
JPS4875564A
(https=)
|
1972-01-08 |
1973-10-11 |
|
|
|
JPS4988862A
(https=)
|
1972-12-29 |
1974-08-24 |
|
|
|
US4883658A
(en)
|
1986-04-28 |
1989-11-28 |
Holly Frank J |
Ophthalmic solution for treatment of dry-eye syndrome
|
|
US4804539A
(en)
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
JPH0788376B2
(ja)
|
1986-09-02 |
1995-09-27 |
エーザイ株式会社 |
光学活性α−トコトリエノ−ルの製造方法
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
US4914088A
(en)
|
1987-04-02 |
1990-04-03 |
Thomas Glonek |
Dry eye treatment solution and method
|
|
JP2685785B2
(ja)
|
1988-03-11 |
1997-12-03 |
エーザイ株式会社 |
光学活性α−トコトリエノールの製造方法
|
|
EP0333472B1
(en)
|
1988-03-16 |
1997-10-08 |
PALM OIL RESEARCH & DEVELOPMENT BOARD |
Production of high concentration tocopherols and tocotrienols from palm oil by-products
|
|
US5075104A
(en)
|
1989-03-31 |
1991-12-24 |
Alcon Laboratories, Inc. |
Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
|
|
US5157132A
(en)
|
1990-05-18 |
1992-10-20 |
Carotech Associates |
Integrated process for recovery of carotenoids and tocotrienols from oil
|
|
US5591772A
(en)
|
1991-11-22 |
1997-01-07 |
Lipogenics, Inc. |
Tocotrienols and tocotrienol-like compounds and methods for their use
|
|
ZA912797B
(en)
|
1990-05-29 |
1992-12-30 |
Boston Ocular Res |
Dry eye treatment process and solution
|
|
DE69115990T2
(de)
|
1990-05-29 |
1996-05-30 |
Ocular Res Of Bonton Inc |
Zusammensetzung zur Behandlung von Dry Eye Erkrankungen
|
|
ZA927277B
(en)
|
1991-10-02 |
1993-05-19 |
Boston Ocular Res |
Dry eye treatment process and solution.
|
|
US5318993A
(en)
*
|
1993-04-16 |
1994-06-07 |
Bristol-Myers Squibb Company |
Antihyperlipidemic benzoquinones
|
|
EP0708646A1
(en)
|
1994-05-06 |
1996-05-01 |
Alcon Laboratories, Inc. |
Use of vitamin e tocopheryl derivatives in ophthalmic compositions
|
|
SK282144B6
(sk)
|
1994-12-28 |
2001-11-06 |
Janssen Pharmaceutica N. V. |
Liečivo na terapeutické a profylaktické ošetrenie degeneratívnych chorôb vaskulárneho systému a nervovej sústavy, ktoré súvisia s oxidačným stresom
|
|
US6232060B1
(en)
|
1996-01-19 |
2001-05-15 |
Galileo Laboratories, Inc. |
Assay system for anti-stress agents
|
|
US5801159A
(en)
|
1996-02-23 |
1998-09-01 |
Galileo Laboratories, Inc. |
Method and composition for inhibiting cellular irreversible changes due to stress
|
|
JP2002501915A
(ja)
|
1998-01-29 |
2002-01-22 |
イーストマン ケミカル カンパニー |
トコール含有混合物からのトコールの分離方法
|
|
WO2000078296A2
(en)
|
1999-06-17 |
2000-12-28 |
Basf Aktiengesellschaft |
Tocotrienol and/or tocotrienol derivatives for the treatment or prophylaxis of glutamate- and/or calcium-induced disorders
|
|
US6395915B1
(en)
|
1999-09-10 |
2002-05-28 |
Technikrom, Inc. |
Method for producing purified tocotrienols and tocopherols using liquid chromatography
|
|
US6528042B1
(en)
|
1999-10-08 |
2003-03-04 |
Galileo Laboratories, Inc. |
Compositions of flavonoids for use as cytoprotectants and methods of making and using them
|
|
US6426362B1
(en)
|
1999-10-08 |
2002-07-30 |
Galileo Laboratories, Inc. |
Formulations of tocopherols and methods of making and using them
|
|
MY127451A
(en)
|
1999-11-04 |
2006-12-29 |
Malaysian Palm Oil Board |
A method of chromatographic isolation for vitamin e isomers
|
|
DE10034233A1
(de)
|
2000-07-14 |
2002-01-24 |
Basf Ag |
Tocotrienolchinon-Cyclisierungsprodukte
|
|
GB0023555D0
(en)
*
|
2000-09-26 |
2000-11-08 |
Inst Of Ophthalmology |
Improvements in and relating to treatments for eye disease
|
|
US7034054B2
(en)
|
2000-12-15 |
2006-04-25 |
Galileo Pharmaceuticals, Inc. |
Methods for the prevention and treatment of cerebral ischemia using non-alpha tocopherols
|
|
WO2002047680A2
(en)
|
2000-12-15 |
2002-06-20 |
Galileo Laboratories, Inc. |
Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
|
|
US6838104B2
(en)
|
2000-12-20 |
2005-01-04 |
Archer Daniels Midland Company |
Process for the production of tocotrienols
|
|
US6608196B2
(en)
|
2001-05-03 |
2003-08-19 |
Galileo Pharmaceuticals, Inc. |
Process for solid supported synthesis of pyruvate-derived compounds
|
|
WO2003015494A2
(en)
|
2001-08-21 |
2003-02-27 |
Galileo Pharmaceuticals, Inc. |
Tocopherol enriched compositions and amelioration of inflammatory symptoms
|
|
AU2002352726A1
(en)
|
2001-11-15 |
2003-06-10 |
Galileo Laboratories, Inc. |
Formulations and methods for treatment or amelioration of inflammatory conditions
|
|
US6667330B2
(en)
|
2002-01-31 |
2003-12-23 |
Galileo Pharmaceuticals, Inc. |
Furanone derivatives
|
|
US7078541B2
(en)
|
2002-02-07 |
2006-07-18 |
Galileo Pharmaceuticals, Inc. |
Benzofuran derivatives
|
|
US6653346B1
(en)
|
2002-02-07 |
2003-11-25 |
Galileo Pharmaceuticals, Inc. |
Cytoprotective benzofuran derivatives
|
|
DE60211875T2
(de)
|
2002-07-01 |
2006-10-26 |
Santhera Pharmaceuticals (Schweiz) Ag |
Screeningverfahren und Verbindungen zur Behandlung von Friedreich ataxia
|
|
JP4599292B2
(ja)
|
2002-10-30 |
2010-12-15 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
物理的−化学的特性に基づく治療用化合物の同定
|
|
US7015243B2
(en)
*
|
2003-08-28 |
2006-03-21 |
Allergan, Inc. |
Cyclohexyl prostaglandin analogs as EP4-receptor agonists
|
|
WO2005033092A1
(en)
|
2003-09-19 |
2005-04-14 |
Galileo Pharmaceuticals, Inc. |
Chroman derivatives
|
|
US20050074447A1
(en)
*
|
2003-10-01 |
2005-04-07 |
Papas Andreas M. |
Treatment for diabetic microvascular and macrovascular complications
|
|
WO2005035490A2
(en)
|
2003-10-10 |
2005-04-21 |
Yasoo Health, Inc. |
PROCESS FOR SYNTHESIZING d-TOCOTRIENOLS
|
|
JP5129563B2
(ja)
|
2004-03-18 |
2013-01-30 |
ラスク・インテレクチュアル・リザーブ・アクチェンゲゼルシャフト |
視神経症に対する感受性を診断または予測するための方法
|
|
DE602004022523D1
(de)
|
2004-07-02 |
2009-09-24 |
Novagali Pharma Sa |
Verwendung von Emulsionen zur intra- und periocularen Injection
|
|
US7393662B2
(en)
|
2004-09-03 |
2008-07-01 |
Centocor, Inc. |
Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
|
|
US20060241174A1
(en)
|
2005-04-22 |
2006-10-26 |
Anne Mueller |
Vitamin E tocotrienols inhibition of intracellularly obligate pathogen Chlamydia and methods of use
|
|
EP2471530B1
(en)
|
2005-06-01 |
2017-01-11 |
Edison Pharmaceuticals, Inc. |
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
CA2622523C
(en)
|
2005-09-15 |
2014-02-18 |
Edison Pharmaceuticals, Inc. |
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
EP1924292A2
(en)
|
2005-09-16 |
2008-05-28 |
Allergan, Inc. |
Compositions and methods for the intraocular transport of therapeutic agents
|
|
US9278085B2
(en)
*
|
2006-02-22 |
2016-03-08 |
Edison Pharmaceuticals, Inc. |
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
|
|
WO2008086025A2
(en)
|
2007-01-10 |
2008-07-17 |
Edison Pharmaceuticals, Inc. |
Treatment of respiratory chain disorders using compounds having erythropoietin or thrombopoietin activity
|
|
WO2008157747A1
(en)
|
2007-06-21 |
2008-12-24 |
The Jackson Laboratory |
Use of inhibition of exonuclease 1 in methods for therapy and diagnostic of neurodegenerative diseases, eye diseases, and mitochondrial disorders
|
|
US20100209436A1
(en)
|
2007-07-03 |
2010-08-19 |
Andreas Reichert |
Method for treating diseases related to mitochondrial dysfunction
|
|
WO2009023877A2
(en)
|
2007-08-16 |
2009-02-19 |
Macusight, Inc. |
Formulations for treatment of ocular diseases or conditions
|
|
US8075909B2
(en)
|
2007-09-04 |
2011-12-13 |
University Of Florida Research Foundation, Incorporated |
Contact lens based bioactive agent delivery system
|
|
WO2009061744A2
(en)
|
2007-11-06 |
2009-05-14 |
Edison Pharmaceuticals, Inc. |
4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
|
|
WO2009088572A2
(en)
|
2008-01-07 |
2009-07-16 |
Centocor, Inc. |
Method of treating erythropoietin hyporesponsive anemias
|
|
EA023618B1
(ru)
|
2008-01-08 |
2016-06-30 |
Эдисон Фармасьютикалз, Инк. |
Производные (гет)арил-п-хинона для лечения митохондриальных болезней
|
|
WO2009111576A2
(en)
|
2008-03-05 |
2009-09-11 |
Edison Pharmaceuticals, Inc. |
2-SUBSTITUTED-p-QUINONE DERIVATIVES FOR TREATMENT OF OXIDATIVE STRESS DISEASES
|
|
EP2262519A4
(en)
|
2008-03-05 |
2011-03-23 |
Edison Pharmaceuticals Inc |
TREATMENT OF HEARING AND BALANCING DISORDERS WITH REDOXACTIVE THERAPEUTICS
|
|
CA2723621A1
(en)
|
2008-05-15 |
2009-11-19 |
Edison Pharmaceuticals, Inc |
Treatment of hearing and balance impairments using compounds having erythropoietin activity
|
|
WO2009143268A2
(en)
|
2008-05-22 |
2009-11-26 |
Edison Pharmaceuticals, Inc. |
Treatment of mitochondrial diseases with an erythropoietin mimetic
|
|
WO2009158348A1
(en)
|
2008-06-25 |
2009-12-30 |
Edison Pharmaceuticals, Inc. |
2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
|
|
WO2010005989A1
(en)
|
2008-07-09 |
2010-01-14 |
Edison Pharmaceuticals, Inc. |
Dermatological compositions with anti-aging and skin even-toning properties
|
|
US20100029784A1
(en)
|
2008-07-30 |
2010-02-04 |
Hinman Andrew W |
Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning properties
|
|
EP2344142B1
(en)
|
2008-09-10 |
2024-06-26 |
PTC Therapeutics, Inc. |
Treatment of pervasive developmental disorders with redox-active therapeutics
|
|
BRPI0920326A2
(pt)
|
2008-10-09 |
2016-02-23 |
Ramscor Inc |
composição e método para tratamento da síndrome do olho ressecado
|
|
EP2362726B1
(en)
|
2008-10-14 |
2018-08-08 |
Bioelectron Technology Corporation |
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
|
|
CA2741767C
(en)
|
2008-10-28 |
2017-09-12 |
Ptc Therapeutics, Inc. |
Process for the production of alpha-tocotrienol and derivatives
|
|
PL2424495T3
(pl)
|
2009-04-28 |
2018-06-29 |
Bioelectron Technology Corporation |
Leczenie dziedzicznej neuropatii nerwów wzrokowych lebera i dominującego zaniku nerwu wzrokowego chinonami tokotrienolu
|
|
JP2012525397A
(ja)
|
2009-04-28 |
2012-10-22 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
眼科疾患を治療するためのトコトリエノールキノンの製剤
|
|
EP2424360A4
(en)
|
2009-04-28 |
2012-10-03 |
Ampere Life Sciences Inc |
TOPICAL, PERIOCULAR OR INTRAOCULAR USE OF TOCOTRIENOLS FOR THE TREATMENT OF OPHTHALMIC DISEASES
|
|
EP2609921A1
(en)
|
2009-06-25 |
2013-07-03 |
Ampere Life Sciences, Inc. |
Treatment of pervasive developmental disorders with tocotrienols or tocotrienol enriched extracts
|
|
DK2470168T3
(en)
|
2009-08-26 |
2018-05-07 |
Bioelectron Tech Corp |
PROCEDURES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCAM
|
|
WO2011041452A2
(en)
|
2009-10-01 |
2011-04-07 |
Ampere Life Sciences, Inc. |
Mouse model for identifying compounds for the treatment of oxidative stress
|
|
US20110172312A1
(en)
|
2009-12-31 |
2011-07-14 |
Miller Guy M |
Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones
|
|
WO2011113018A1
(en)
|
2010-03-12 |
2011-09-15 |
Ampere Life Sciences, Inc. |
Measurement and control of biological time
|
|
AU2011238525A1
(en)
|
2010-04-06 |
2012-11-08 |
Edison Pharmaceuticals, Inc. |
Treatment of Ataxia Telangiectasia
|
|
CA2797581A1
(en)
|
2010-04-27 |
2011-11-03 |
Edison Pharmaceuticals, Inc. |
Formulations of quinones for the treatment of ophthalmic diseases
|
|
US20120101169A1
(en)
|
2010-07-14 |
2012-04-26 |
Penwest Pharmaceuticals Co. |
Methods of providing anticoagulation effects in subjects
|
|
EA201300215A1
(ru)
|
2010-08-06 |
2013-07-30 |
Эдисон Фармасьютикалз, Инк. |
Лечение митохондриальных болезней нафтохинонами
|
|
EP2601168A4
(en)
|
2010-08-06 |
2013-12-04 |
Ampere Life Sciences Inc |
TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K
|
|
WO2012068552A1
(en)
|
2010-11-19 |
2012-05-24 |
Edison Pharmaceuticals, Inc. |
Methods for improving blood glucose control
|
|
WO2012154613A1
(en)
|
2011-05-06 |
2012-11-15 |
Edison Pharmaceuticals, Inc. |
Improved process for the preparation of d-alpha-tocotrienol from natural extracts
|
|
WO2012170773A1
(en)
|
2011-06-08 |
2012-12-13 |
Edison Pharmaceuticals, Inc. |
Adjunctive therapy for the treatment of mitochondrial disorders with quinones and naphthoquinones
|
|
WO2012174286A1
(en)
|
2011-06-14 |
2012-12-20 |
Edison Pharmaceuticals, Inc. |
Catechol derivatives for treatment of oxidative stress diseases
|
|
WO2013006736A1
(en)
|
2011-07-06 |
2013-01-10 |
Edison Pharmaceuticals, Inc |
Treatment of leigh syndrome and leigh-like syndrome, including complications of sucla2 mutations, with tocotrienol quinones
|
|
US20150057363A1
(en)
|
2011-07-06 |
2015-02-26 |
Guy M. Miller |
Treatment of methylmalonic aciduria, isovaleric aciduria, and other organic acidurias with tocotrienol quinones
|
|
JP2014520894A
(ja)
|
2011-07-19 |
2014-08-25 |
エジソン ファーマシューティカルズ， インコーポレイテッド |
非アルファトコトリエノールの存在下でのアルファトコトリエノールの選択的酸化のための方法
|
|
CA2883879A1
(en)
|
2012-09-07 |
2014-03-13 |
Edison Pharmaceuticals, Inc. |
Quinone derivatives for use in the modulation of redox status of individuals
|
|
EA031098B1
(ru)
|
2013-03-08 |
2018-11-30 |
Юнилевер Н.В. |
Соединения резорцина для дерматологического применения
|
|
US10189830B2
(en)
|
2013-03-15 |
2019-01-29 |
Bioelectron Technology Corporation |
Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disorders
|
|
US9868711B2
(en)
|
2013-03-15 |
2018-01-16 |
Bioelectron Technology Corporation |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US20140275045A1
(en)
|
2013-03-15 |
2014-09-18 |
Edison Pharmaceuticals, Inc. |
Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disorders
|
|
US9670170B2
(en)
|
2013-03-15 |
2017-06-06 |
Bioelectron Technology Corporation |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
US9296712B2
(en)
|
2013-03-15 |
2016-03-29 |
Edison Pharmaceuticals, Inc. |
Resorufin derivatives for treatment of oxidative stress disorders
|
|
AU2014273891A1
(en)
|
2013-05-31 |
2015-12-24 |
Bioelectron Technology Corporation |
Carboxylic acid derivatives for treatment of oxidative stress disorders
|